Scibase: Initial order from Castle for clinical study - Redeye

Redeye provides a brief comment on Scibase receiving an initial order valued at approximately SEK8m from Castle Biosciences. The order covers Nevisense Go and electrodes intended for use in an upcoming clinical study. The order underscores Castle’s commitment to its collaboration with Scibase.

Länk till analysen i sin helhet: https://www.redeye.se/research/1128610/scibase-initial-order-from-castle-for-clinical-study?utm_source=finwire&utm_medium=RSS